Collaborative Stage for TNM 7 - Revised 01/25/2010

CorpusSarcoma

Corpus Uteri; Uterus, NOS (excluding Placenta)

(Leiomyosarcomas and endometrial stromal sarcomas)

C54.0-C54.3, C54.8-C54.9, C55.9

CS Tumor Size
CS Extension
CS Tumor Size/Ext Eval
CS Lymph Nodes
CS Lymph Nodes Eval
Reg LN Pos
Reg LN Exam
CS Mets at DX
CS Mets Eval
CS Site-Specific Factor 1
FIGO Stage
CS Site-Specific Factor 2
Peritoneal Cytology
CS Site-Specific Factor 3
Number of Positive Pelvic Nodes
CS Site-Specific Factor 4
Number of Examined Pelvic Nodes
CS Site-Specific Factor 5
Number of Positive Para-Aortic Nodes
CS Site-Specific Factor 6
Number of Examined Para-Aortic Nodes
 CS Site-Specific Factor 7
Percentage of Non-Endometrioid Cell Type in Mixed Histology Tumors
CS Site-Specific Factor 8
Omentectomy
CS Site-Specific Factor 9 = 988
CS Site-Specific Factor 10 = 988
CS Site-Specific Factor 11 = 988
CS Site-Specific Factor 12 = 988
CS Site-Specific Factor 13 = 988
CS Site-Specific Factor 14 = 988
CS Site-Specific Factor 15 = 988
CS Site-Specific Factor 16 = 988
CS Site-Specific Factor 17 = 988
CS Site-Specific Factor 18 = 988
CS Site-Specific Factor 19 = 988
CS Site-Specific Factor 20 = 988
CS Site-Specific Factor 21 = 988
CS Site-Specific Factor 22 = 988
CS Site-Specific Factor 23 = 988
CS Site-Specific Factor 24 = 988
CS Site-Specific Factor 25 = 988
Histology Inclusion Table AJCC 7th ed.
Histology Exclusion Table AJCC 6th ed.
AJCC TNM 7 Stage
AJCC TNM 6 Stage
Summary Stage
Extension Size Table
CS Tumor Extension Cytology Table
Revision Info   List of Schemas